More yield less variability

AI guided apheresis

Technology

CuraNova’s advanced apheresis systems integrate artificial intelligence and automation to redefine blood component separation. Our technology focuses on delivering unmatched accuracy, reliability, and safety for clinicians and patients alike. Discover the innovative features that set CuraNova apart in medical device solutions.

AI-Powered Adaptive Automation

CuraNova’s technology integrates artificial intelligence directly into the heart of apheresis — transforming a traditionally manual, reactive process into a predictive, adaptive system that enhances every stage of blood component separation.

Our AI platform continuously learns from patient data, real-time feedback, and thousands of prior procedures. The result is faster, safer, and more consistent therapies with fewer manual adjustments and less variability between operators or facilities.

Our intelligent systems automatically adjust apheresis parameters in real time, optimizing cell separation for each patient profile and clinical need.

✓ Enhanced Efficiency and Workflow

✓ Consistent Therapeutic Results

✓ Reduced Manual Intervention

✓ Integrated Safety Intelligence

✓ Automated Calibration and Learning

✓ Predictive Procedure Management

Why CuraNova?

Setting a New Standard in Blood Technology

While traditional apheresis systems rely on static settings and manual adjustments, CuraNova introduces intelligent automation that learns in real time. Our technology doesn’t just separate components — it improves every outcome, optimizes every cycle, and empowers every clinician who uses it.

By merging clinical expertise with adaptive AI, CuraNova is redefining what safety, precision, and efficiency mean in therapeutic blood processing.

%
Accuracy rate in preliminary clinical simulations
+
Successful test procedures across partner hospitals and labs
%
Reduction in manual intervention time compared to legacy systems

Contact

Partner with CuraNova to Advance Blood Technology

At CuraNova, we collaborate with healthcare providers, researchers, and clinical innovators to advance the future of apheresis and blood component separation. Whether you’re exploring AI-driven automation, seeking product support, or interested in partnership opportunities, our team is here to help.

Top of page